Kathleen E Walsh1, Colleen Biggins2, Deb Blasko2, Steven M Christiansen2, Shira H Fischer2, Christopher Keuker2, Robert Klugman2, Kathleen M Mazor2. 1. Cincinnati Children's Hospital, Cincinnati, OH; The Meyers Primary Care Institute; University of Massachusetts; Reliant Medical Group, Worcester; Beth Israel Deaconess Medical Center, Boston; Kindred Healthcare, North Andover, MA; and InterVision Media, Eugene, OR Kathleen.walsh@cchmc.org. 2. Cincinnati Children's Hospital, Cincinnati, OH; The Meyers Primary Care Institute; University of Massachusetts; Reliant Medical Group, Worcester; Beth Israel Deaconess Medical Center, Boston; Kindred Healthcare, North Andover, MA; and InterVision Media, Eugene, OR.
Abstract
PURPOSE: Errors in the use of medications at home by children with cancer are common, and interventions to support correct use are needed. We sought to (1) engage stakeholders in the design and development of an intervention to prevent errors in home medication use, and (2) evaluate the acceptability and usefulness of the intervention. METHODS: We convened a multidisciplinary team of parents, clinicians, technology experts, and researchers to develop an intervention using a two-step user-centered design process. First, parents and oncologists provided input on the design. Second, a parent panel and two oncology nurses refined draft materials. In a feasibility study, we used questionnaires to assess usefulness and acceptability. Medication error rates were assessed via monthly telephone interviews with parents. RESULTS: We successfully partnered with parents, clinicians, and IT experts to develop Home Medication Support (HoMeS), a family-centered Web-based intervention. HoMeS includes a medication calendar with decision support, a communication tool, adverse effect information, a metric conversion chart, and other information. The 15 families in the feasibility study gave HoMeS high ratings for acceptability and usefulness. Half recorded information on the calendar to indicate to other caregivers that doses were given; 34% brought it to the clinic to communicate with their clinician about home medication use. There was no change in the rate of medication errors in this feasibility study. CONCLUSION: We created and tested a stakeholder-designed, Web-based intervention to support home chemotherapy use, which parents rated highly. This tool may prevent serious medication errors in a larger study.
PURPOSE: Errors in the use of medications at home by children with cancer are common, and interventions to support correct use are needed. We sought to (1) engage stakeholders in the design and development of an intervention to prevent errors in home medication use, and (2) evaluate the acceptability and usefulness of the intervention. METHODS: We convened a multidisciplinary team of parents, clinicians, technology experts, and researchers to develop an intervention using a two-step user-centered design process. First, parents and oncologists provided input on the design. Second, a parent panel and two oncology nurses refined draft materials. In a feasibility study, we used questionnaires to assess usefulness and acceptability. Medication error rates were assessed via monthly telephone interviews with parents. RESULTS: We successfully partnered with parents, clinicians, and IT experts to develop Home Medication Support (HoMeS), a family-centered Web-based intervention. HoMeS includes a medication calendar with decision support, a communication tool, adverse effect information, a metric conversion chart, and other information. The 15 families in the feasibility study gave HoMeS high ratings for acceptability and usefulness. Half recorded information on the calendar to indicate to other caregivers that doses were given; 34% brought it to the clinic to communicate with their clinician about home medication use. There was no change in the rate of medication errors in this feasibility study. CONCLUSION: We created and tested a stakeholder-designed, Web-based intervention to support home chemotherapy use, which parents rated highly. This tool may prevent serious medication errors in a larger study.
Authors: Christopher P Landrigan; Jeffrey M Rothschild; John W Cronin; Rainu Kaushal; Elisabeth Burdick; Joel T Katz; Craig M Lilly; Peter H Stone; Steven W Lockley; David W Bates; Charles A Czeisler Journal: N Engl J Med Date: 2004-10-28 Impact factor: 91.245
Authors: Kathleen E Walsh; Kathleen M Mazor; Christopher J Stille; Irma Torres; Joann L Wagner; Juliet Moretti; Kevin Chysna; Christy D Stine; G Naheed Usmani; Jerry H Gurwitz Journal: Arch Dis Child Date: 2011-03-27 Impact factor: 3.791
Authors: Heather A McPhillips; Christopher J Stille; David Smith; Julia Hecht; John Pearson; John Stull; Kristin Debellis; Susan Andrade; Marlene Miller; Rainu Kaushal; Jerry Gurwitz; Robert L Davis Journal: J Pediatr Date: 2005-12 Impact factor: 4.406
Authors: Kathleen E Walsh; Douglas W Roblin; Saul N Weingart; Kathleen E Houlahan; Barbara Degar; Amy Billett; Christopher Keuker; Colleen Biggins; Justin Li; Karen Wasilewski; Kathleen M Mazor Journal: Pediatrics Date: 2013-04-29 Impact factor: 7.124
Authors: D W Bates; L L Leape; D J Cullen; N Laird; L A Petersen; J M Teich; E Burdick; M Hickey; S Kleefield; B Shea; M Vander Vliet; D L Seger Journal: JAMA Date: 1998-10-21 Impact factor: 56.272
Authors: Kathleen E Walsh; Katherine S Dodd; Kala Seetharaman; Douglas W Roblin; Lisa J Herrinton; Ann Von Worley; G Naheed Usmani; David Baer; Jerry H Gurwitz Journal: J Clin Oncol Date: 2008-12-29 Impact factor: 44.544
Authors: Kathleen E Walsh; Christopher P Landrigan; William G Adams; Robert J Vinci; John B Chessare; Maureen R Cooper; Pamela M Hebert; Elisabeth G Schainker; Thomas J McLaughlin; Howard Bauchner Journal: Pediatrics Date: 2008-03 Impact factor: 7.124
Authors: Kathleen E Walsh; Kathleen M Mazor; Douglas Roblin; Colleen Biggins; Joann L Wagner; Kathleen Houlahan; Justin W Li; Christopher Keuker; Karen Wasilewski-Masker; Jennifer Donovan; Abir Kanaan; Saul N Weingart Journal: J Oncol Pract Date: 2013-01 Impact factor: 3.840
Authors: George Demiris; Karla Washington; Connie M Ulrich; Mihail Popescu; Debra Parker Oliver Journal: Semin Oncol Nurs Date: 2019-06-19 Impact factor: 2.315
Authors: James M Hoffman; Nicholas J Keeling; Christopher B Forrest; Heather L Tubbs-Cooley; Erin Moore; Emily Oehler; Stephanie Wilson; Elisabeth Schainker; Kathleen E Walsh Journal: Pediatrics Date: 2019-02 Impact factor: 7.124